Home›Search›Uspehi Molekularnoj Onkologii

Uspehi Molekularnoj Onkologii

ABC-press Publishing House · Russian Federation · Est. 2015

ISSN2413-3787

SJR Q4✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.126

H-Indexi

SNIPi

0.216

Total Worksi

406

Total Citationsi

558

2yr Mean Citednessi

0.37

Open Impact Factor alternative

Aims & Scope

Advances in molecular oncology is a quarterly peer-reviewed journal of research and practice. Target audience: oncologists, molecular biologists, geneticists, biochemists, virologists, cancer epidemiologists, chemotherapists. Information content: reviews, mini-reviews, brief communications and full-size research articles, comments of leading experts. Editorial board members and authors of the journal are the leading Russian and foreign oncologists, molecular biologists, geneticists, chemotherapists and specialists of related professions.

General Information

Country / RegionRussian Federation

Primary LanguageRussian, English

1st Year Published2015

Frequency4 issues per year

StatusActive (last: 2025)

Total Publications406

Publisher OrgABV-press

OA Since2014

Visit Journal Website

Submission Info

Peer Reviewpeer-reviewed

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

7/11 · 64%

✅

Do you know the journal / publisher?

ABC-press Publishing House

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2413-3787

✅

Indexed in a trusted database?

Scopus

✅

Peer review process documented?

peer-reviewed

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

Russian, English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Biochemistry (medical)Q4

Cancer ResearchQ4

Genetics (clinical)Q4

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q4

Subject Classification

Scopus Categories

Cancer ResearchBiochemistry (medical)Genetics (clinical)Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Research Topics (OpenAlex)

MicroRNA in disease regulationCancer Immunotherapy and BiomarkersCancer Cells and MetastasisCancer Genomics and DiagnosticsGenetic factors in colorectal cancerEpigenetics and DNA MethylationImmunotherapy and Immune ResponsesCancer-related molecular mechanisms researchNeuroblastoma Research and TreatmentsCircular RNAs in diseases

Frequently asked questions about Uspehi Molekularnoj Onkologii

Is Uspehi Molekularnoj Onkologii a predatory journal?

PubScope has no integrity flags on record for Uspehi Molekularnoj Onkologii: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Uspehi Molekularnoj Onkologii?

Uspehi Molekularnoj Onkologii is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.126.

Is Uspehi Molekularnoj Onkologii indexed in Scopus and Web of Science?

Uspehi Molekularnoj Onkologii is indexed in Scopus.